73 related articles for article (PubMed ID: 22742880)
1. Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study).
Lebbe C; Lorigan P; Ascierto P; Testori A; Bédane C; Middleton M; van Baardewijk M; Konto C; Dueymes A; Maio M
Eur J Cancer; 2012 Nov; 48(17):3205-14. PubMed ID: 22742880
[TBL] [Abstract][Full Text] [Related]
2. Treatment patterns and outcomes in patients with advanced melanoma in France.
Bedane C; Leccia MT; Sassolas B; Bregman B; Lebbé C;
Curr Med Res Opin; 2013 Oct; 29(10):1297-305. PubMed ID: 23808961
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
[TBL] [Abstract][Full Text] [Related]
4. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
6. Isolated limb perfusion for unresectable melanoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
[TBL] [Abstract][Full Text] [Related]
7. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
8. TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma.
Hsueh EC; Gupta RK; Qi K; Yee R; Leopoldo ZC; Morton DL
Cancer J Sci Am; 1997; 3(6):364-70. PubMed ID: 9403050
[TBL] [Abstract][Full Text] [Related]
9. Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma.
Richtig E; Ludwig R; Kerl H; Smolle J
Br J Dermatol; 2005 Nov; 153(5):925-31. PubMed ID: 16225601
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting the outcome after treatment for metastatic melanoma to the brain.
Carrubba CJ; Vitaz TW
Surg Neurol; 2009 Dec; 72(6):707-11. PubMed ID: 19604550
[TBL] [Abstract][Full Text] [Related]
12. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
[TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors in patients with brain metastases from malignant melanoma.
Meier S; Baumert BG; Maier T; Wellis G; Burg G; Seifert B; Dummer R
Onkologie; 2004 Apr; 27(2):145-9. PubMed ID: 15138346
[TBL] [Abstract][Full Text] [Related]
14. Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.
Bottoni U; Bonaccorsi P; Devirgiliis V; Panasiti V; Borroni RG; Trasimeni G; Clerico R; Calvieri S
Jpn J Clin Oncol; 2005 Sep; 35(9):507-13. PubMed ID: 16120623
[TBL] [Abstract][Full Text] [Related]
15. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience.
Sánchez-Ortiz R; Huang SF; Tamboli P; Prieto VG; Hester G; Pettaway CA
J Urol; 2005 Jun; 173(6):1958-65. PubMed ID: 15879790
[TBL] [Abstract][Full Text] [Related]
16. Gamma knife radiosurgery for malignant melanoma brain metastases.
Seung SK; Sneed PK; McDermott MW; Shu HK; Leong SP; Chang S; Petti PL; Smith V; Verhey LJ; Wara WM; Phillips TL; Larson DA
Cancer J Sci Am; 1998; 4(2):103-9. PubMed ID: 9532412
[TBL] [Abstract][Full Text] [Related]
17. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
18. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
[TBL] [Abstract][Full Text] [Related]
19. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
Wakelee HA; Bernardo P; Johnson DH; Schiller JH
Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
[TBL] [Abstract][Full Text] [Related]
20. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
